Should wealthy nations be procuring booster doses?

Owen Schaefer, an Assistant Professor at the Center for Biomedical Ethics, dives into global vaccine equity challenges. He discusses the ethical dilemmas posed by wealthy nations procuring booster doses while countries still face shortages. Schaefer unpacks the tension between national interests and the urgent need for equitable access, highlighting the role of pharmaceutical companies. The dialogue also addresses the implications of intellectual property rights on vaccine distribution and the moral responsibilities shared by affluent nations during a pandemic.